Skip to main content

Matt Davidson, PhD

Equibles does not estimate personal net worth.

Get an email with a short summary when Azora Therapeutics, Inc. (DE) publishes a filing, an earnings call transcript or a press release.

Get AZR alerts

About Matt Davidson, PhD

Matt Davidson, PhD is recorded as Board Member at Azora Therapeutics, Inc. (DE) (AZR) since June 11, 2026. Azora Therapeutics, Inc. (DE) reported in an 8-K filed June 11, 2026 that Matt Davidson, PhD was appointed newly appointed director. Azora Therapeutics, Inc. (DE) is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Azora Therapeutics, Inc. (DE) includes Matthew Davidson (CEO), Matthew Davidson, Ph.D. (CEO), William B. Stilley (CEO) and 7 others.

“said Matt Davidson, PhD, co-Founder of Azora Therapeutics and incoming chief development officer and newly appointed director of Adial.”
Azora Therapeutics, Inc. (DE) Form 8-K, filed June 11, 2026 · Read the filing

Affiliation history

Company network

Leadership on record at Azora Therapeutics, Inc. (DE)

Recent activity